GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptose Biosciences Inc (TSX:APS) » Definitions » Inventories, Other

Aptose Biosciences (TSX:APS) Inventories, Other : C$0.00 Mil (As of Dec. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Aptose Biosciences Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Aptose Biosciences's other inventories for the quarter that ended in Dec. 2024 was C$0.00 Mil.


Aptose Biosciences Inventories, Other Historical Data

The historical data trend for Aptose Biosciences's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptose Biosciences Inventories, Other Chart

Aptose Biosciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Aptose Biosciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Aptose Biosciences Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.


Aptose Biosciences Business Description

Traded in Other Exchanges
Address
66 Wellington Street West, Suite 5300, TD Bank Tower Box 48, Toronto, ON, CAN, M5K 1E6
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.
Executives
Bernd Robert Seizinger Director
William Glenn Rice Director, Senior Officer
Erich Platzer Director
Rafael Bejar Senior Officer
Warren Whitehead Director
Gregory Kwok Lee Chow Senior Officer
Jotin Marango Senior Officer

Aptose Biosciences Headlines

No Headlines